CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-03 | O'Neill Gilmore Neil EVP, R&D & CMO | Grant or award | +15,000 | 29,070 | ||
| 2021-03-03 | O'Neill Gilmore Neil EVP, R&D & CMO | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-03-03 | Nicaise Claude Director | Grant or award | +2,726 | 11,852 | ||
| 2021-03-03 | Nicaise Claude Director | Grant or award · Stock Option (right to buy) | +5,518 | 5,518 | ||
| 2021-03-03 | MARTIN JOHN C Director | Grant or award | +2,726 | 7,913 | ||
| 2021-03-03 | MARTIN JOHN C Director | Grant or award · Stock Option (right to buy) | +5,518 | 5,518 | ||
| 2021-03-03 | GRAY MARY ANN Director | Grant or award | +2,726 | 8,436 | ||
| 2021-03-03 | GRAY MARY ANN Director | Grant or award · Stock Option (right to buy) | +5,518 | 5,518 | ||
| 2021-03-03 | Estepan Ian Michael Chief Financial Officer | Grant or award | +15,000 | 29,042 | ||
| 2021-03-03 | Estepan Ian Michael Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-03-03 | Ciambrone William EVP | Grant or award | +15,000 | 15,000 | ||
| 2021-03-03 | Ciambrone William EVP | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-03-03 | Brown Ryan Edward SVP, General Counsel | Grant or award | +15,000 | 19,838 | ||
| 2021-03-03 | Brown Ryan Edward SVP, General Counsel | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-03-03 | Barry Richard Director | Grant or award | +2,726 | 3,125,366 | ||
| 2021-03-03 | Barry Richard Director | Grant or award · Stock Option (right to buy) | +5,518 | 5,518 | ||
| 2021-03-03 | BEHRENS M KATHLEEN Director | Grant or award | +2,726 | 130,517 | ||
| 2021-03-03 | BEHRENS M KATHLEEN Director | Grant or award · Stock Option (right to buy) | +5,518 | 5,518 | ||
| 2021-02-28 | O'Neill Gilmore Neil EVP, R&D & CMO | Shares withheld for taxes | −524 | $86.97 | $46K | 13,546 |
| 2021-02-28 | Brown Ryan Edward SVP, General Counsel | Shares withheld for taxes | −216 | $86.97 | $19K | 4,622 |
Page 21 of 22 · 424 trades